Skip to the page

Data / Form D filings / AiTA Bio Inc.

AiTA Bio Inc.: Form D filing

AiTA Bio Inc., a manufacturing company in New York, NY, filed a Form D with the SEC in 2025. The latest, on January 14, 2025, reports $10 million sold of an offering with no set size to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
139 5TH AVENUE, FLOOR 5, New York, NY, 10010
Phone
(732) 768-2528
Industry
Manufacturing
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2051873

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 14, 2025New noticeIndefinite$10,000,0091Jan 13, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jacob MentureExecutive Officer, Director, Promoter
Dilan CasanovasExecutive Officer, Director

Other manufacturing companies in New York that filed recently

Every Form D from the week of Jan 13, 2025 · All recent filings in New York · All recent Manufacturing filings

Read from SEC EDGAR. Amount sold is what AiTA Bio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.